Evidence map›Paper›PMID 34611161›Full record

ArticleNature communications2021

Scientific prizes and the extraordinary growth of scientific topics.

Ching Jin, Yifang Ma, Brian Uzzi

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. The distinctive innovation patterns and network embeddedness of scientific prizewinners.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Promotional language and the adoption of innovative ideas in science.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Impactful scientists have higher tendency to involve collaborators in new topics.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ching JinNorthwestern Institute on Complex Systems (NICO), Northwestern University, Evanston, IL, USA.ORCID 0000-0003-2509-4034
Yifang MaNorthwestern Institute on Complex Systems (NICO), Northwestern University, Evanston, IL, USA.ORCID 0000-0003-0326-7993
Brian UzziNorthwestern Institute on Complex Systems (NICO), Northwestern University, Evanston, IL, USA. uzzi@northwestern.edu.ORCID 0000-0001-6855-2854

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fast growing scientific topics have famously been key harbingers of the new frontiers of science, yet, large-scale analyses of their genesis and impact are rare. We investigated one possible factor connected with a topic's extraordinary growth: scientific prizes. Our longitudinal analysis of nearly all recognized prizes worldwide and over 11,000 scientific topics from 19 disciplines indicates that topics associated with a scientific prize experience extraordinary growth in productivity, impact, and new entrants. Relative to matched non-prizewinning topics, prizewinning topics produce 40% more papers and 33% more citations, retain 55% more scientists, and gain 37 and 47% more new entrants and star scientists, respectively, in the first five-to-ten years after the prize. Funding do not account for a prizewinning topic's growth. Rather, growth is positively related to the degree to which the prize is discipline-specific, conferred for recent research, or has prize money. These findings reveal new dynamics behind scientific innovation and investment.

Identifiers

PMID34611161
PMCPMC8492701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.